An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.
Experimental Drug Acquiring Traction Via Social Media
The experimental drug, which is still in research studies, is being promoted by online personalities for its supposed weight-reducing properties. Viewers are urged to message these profiles directly for supplier links, while also obtaining promotional offers.
Active Commerce on Social Networks
Separately, a robust market exists on messaging services, where groups with thousands of members share comparison photos, injection guides and assertions of next-day British shipping. Vendors market the drug there before directing customers to other platforms for purchases.
Learning About The Experimental Drug
Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Experts Express Concerns
Nevertheless, physicians and chemists have cautions that the distribution of what is still an unapproved drug in the UK is worrisome and could lead to individuals administering substances of unknown origin.
Several professionals stated the popularity for retatrutide could be connected to the rising price of licensed slimming products such as Mounjaro.
Regulatory Position and Enforcement
Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or supplied for personal consumption under the British medical regulations.
Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate pharmaceutical, marketing, and consumer regulations, risking penalties, legal action or prison.
Platform Reaction and Content Removal
According to TikTok, the service has taken down violative content and prohibited related hashtags and query recommendations. The organization said it was committed to keeping the service secure and investing in enhancing enforcement strategies.
Digital Trading Activities
Investigations also found communities with up to 9,000 participants selling the experimental drug using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of members, populated with images of slimming results, positive reviews and step-by-step guides for preparing or injecting at home.
Within minutes of entering one group, a vendor posted contact information, where most transactions take place. The vendor provided an instruction manual and guaranteed delivery within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about weight, medical conditions or previous experience.
Item Information and Pricing
Within these communities, messages show black plastic parcels with postal service stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with sterile water, or pre-filled pens typically sold at 160 pounds for 20mg. When asked how long a injector should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A representative for Telegram stated it regularly monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting substances they cannot confirm. Although the research behind this drug is sound, these online versions may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor linked the surge in interest to current cost increases for approved slimming medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are highly risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.
Her staff has previously encountered patients injured by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company investigational product not yet authorized … may subject users to possibly serious health risks”.
